Liliya V. Cheskidova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liliya V. Cheskidova has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Vitaliy I. Zimnikov
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
6 shared publications - G. G. Chusova
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
4 shared publications - O. B. Pavlenko
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
4 shared publications - I. V. Bryukhova
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
3 shared publications - Nikolay Klimov
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
3 shared publications - T. G. Ermolova
All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy
3 shared publications
Latest Publications
- Open Access
- 19 August 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 2,p. 80-84
Modulation of cellular immunity, IFNAR1 and IKBKB gene expression in the treatment of calves with bronchopneumonia
The article presents an assessment of the effect of complex therapy of respiratory pathology on the expression of IFNAR1, IKBKB genes and indicators of cellular immunity in 3-month-old calves. Threegroups were formed for the experiment: healthy animals (n=10) – group I; sick calves treated with «Azitronit» and «Butophan» (n=10) — group II; sick calves treated with «Azitronit» and «Proautovac» (n=10) — group III. It was found that after 5 days, IFNAR1 expression in all the studied groups approached the values of healthy animals, and after 7 days it was completely suppressed. The expression of the IKBKB gene in group II calves 7 days after the start of treatment corresponded to the indicators of group I animals, and in group III calves it was 2 times lower. 5 and 7 days after the start of treatment with «Proautovac», a significant increase in the PhAL was recorded by 3,4 % and 4,3 % in calves compared with group II. The PhI and PhN in group III animals were higher than in group II by 11,3 % and 10,0 % 60 hours after the start of treatment, by 21,3 % and 28,2 % after 5 days, and by 18,1 % and 14,2 % after 7 days. 7 days after the start of treatment, the blood levels of B- and T lymphocytes in group III calves were 21,0 % and 29,2 % higher than when using «Butophan». At the end of the experiment, the indicators of cellular immunity when using «Proautovac» did not differ statistically significantly from healthy animals. Thus, the use of «Proautovac» provided faster normalization and restoration of signaling pathways and cellular mechanisms of immunity, which justifies the use of cytokine-based drugs (type I/II interferons, GM-CSF and vitamins A, E, and C) in the complex treatment of bronchopneumonia in calves.
- 19 August 2026
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 2,p. 80-84
Open AccessModulation of cellular immunity, IFNAR1 and IKBKB gene expression in the treatment of calves with bronchopneumonia
The article presents an assessment of the effect of complex therapy of respiratory pathology on the expression of IFNAR1, IKBKB genes and indicators of cellular immunity in 3-month-old calves. Threegroups were formed for the experiment: healthy animals (n=10) – group I; sick calves treated with «Azitronit» and «Butophan» (n=10) — group II; sick calves treated with «Azitronit» and «Proautovac» (n=10) — group III. It was found that after 5 days, IFNAR1 expression in all the studied groups approached the values of healthy animals, and after 7 days it was completely suppressed. The expression of the IKBKB gene in group II calves 7 days after the start of treatment corresponded to the indicators of group I animals, and in group III calves it was 2 times lower. 5 and 7 days after the start of treatment with «Proautovac», a significant increase in the PhAL was recorded by 3,4 % and 4,3 % in calves compared with group II. The PhI and PhN in group III animals were higher than in group II by 11,3 % and 10,0 % 60 hours after the start of treatment, by 21,3 % and 28,2 % after 5 days, and by 18,1 % and 14,2 % after 7 days. 7 days after the start of treatment, the blood levels of B- and T lymphocytes in group III calves were 21,0 % and 29,2 % higher than when using «Butophan». At the end of the experiment, the indicators of cellular immunity when using «Proautovac» did not differ statistically significantly from healthy animals. Thus, the use of «Proautovac» provided faster normalization and restoration of signaling pathways and cellular mechanisms of immunity, which justifies the use of cytokine-based drugs (type I/II interferons, GM-CSF and vitamins A, E, and C) in the complex treatment of bronchopneumonia in calves.
- 31 March 2025
- Published by All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy in BULLETIN OF VETERINARY PHARMACOLOGY
- No. 1(30),p. 51-62
ЭФФЕКТИВНОСТЬ КОМПЛЕКСНОЙ СХЕМЫ ЛЕЧЕНИЯ МАСТИТА У КОРОВ С ПРИМЕНЕНИЕМ ПРЕПАРАТА «ДИОМАСТ-КРС» И ЛИПОТОНА
В статье представлены результаты изучения эффективности схемы лечения мастита у коров, включающей применение комплексного препарата «Диомаст-КРС» и Липотона. Для проведения экспериментальных исследований было отобрано 49 коров, больных маститом, которые по принципу аналогов были распределены в 2 группы. Животным первой группы применяли Диомаст-КРС согласно инструкции, второй группе дополнительно внутримышечно вводили Липотон в дозе 0,02 мл/кг двукратно с интервалом 48 часов. Установлено, что наилучший терапевтический эффект получен при совместном применении Липотона и Диомаста-КРС, который при гнойно-катаральной форме мастита составил 92,3 %, при катаральной — 91,7 %, что выше показателей базового варианта на 7,7—9,9 %, при этом излечено 93,3 и 92,3 % долей вымени соответственно. Контаминация молока микрофлорой снизилась при введении Диомаста-КРС в 4 раза, а при дополнительном использовании Липотона — в 6 раз и при этом бактерионосительство было ниже в 1,5 раза. Терапия больных маститом коров при применении Липотона сопровождалась более ранним купированием воспалительного процесса в молочной железе, выраженной активизацией гуморального и клеточного звена естественной резистентности, интенсивным снижением процессов пероксидации липидов и активизацией ферментативного и неферментативного звена антиоксидантной защиты. The article presents the results of studying the efficacy of the therapeutic regimen for bovine mastitis, including the use of the complex drug “Diomast-KRS” and Lipoton. For experimental studies, 49 cows with mastitis were selected, which were divided into 2 groups according to the principle of analogues. The animals of the first group were given “Diomast-KRS” according to the instructions, the second group was additionally administered Lipoton intramuscularly at a dose of 0.02 ml/kg twice with an interval of 48 hours. It had been found that the best therapeutic effect was obtained with the combined use of Lipoton and “Diomast-KRS”, which was 92.3 % for purulent-catarrhal mastitis, 91.7 % — for catarrhal mastitis, which was by 7.7—9.9 % higher than the baseline values, while 93.3 and 92.3 % of the udder lobes were cured, respectively. Milk contamination with microflora decreased by 4 times with the introduction of “Diomast-KRS”, and by 6 times with the additional use of Lipoton, while the bacterial carriage was by 1.5 times lower. Therapy of cows with mastitis using Lipoton was accompanied by earlier relief of the inflammatory process in the mammary gland, pronounced activation of the humoral and cellular links of natural resistance, an intensive decrease in lipid peroxidation processes and activation of the enzymatic and non-enzymatic links of antioxidant protection.
- 31 March 2025
- Published by All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy in BULLETIN OF VETERINARY PHARMACOLOGY
- No. 1(30),p. 51-62
ЭФФЕКТИВНОСТЬ КОМПЛЕКСНОЙ СХЕМЫ ЛЕЧЕНИЯ МАСТИТА У КОРОВ С ПРИМЕНЕНИЕМ ПРЕПАРАТА «ДИОМАСТ-КРС» И ЛИПОТОНА
В статье представлены результаты изучения эффективности схемы лечения мастита у коров, включающей применение комплексного препарата «Диомаст-КРС» и Липотона. Для проведения экспериментальных исследований было отобрано 49 коров, больных маститом, которые по принципу аналогов были распределены в 2 группы. Животным первой группы применяли Диомаст-КРС согласно инструкции, второй группе дополнительно внутримышечно вводили Липотон в дозе 0,02 мл/кг двукратно с интервалом 48 часов. Установлено, что наилучший терапевтический эффект получен при совместном применении Липотона и Диомаста-КРС, который при гнойно-катаральной форме мастита составил 92,3 %, при катаральной — 91,7 %, что выше показателей базового варианта на 7,7—9,9 %, при этом излечено 93,3 и 92,3 % долей вымени соответственно. Контаминация молока микрофлорой снизилась при введении Диомаста-КРС в 4 раза, а при дополнительном использовании Липотона — в 6 раз и при этом бактерионосительство было ниже в 1,5 раза. Терапия больных маститом коров при применении Липотона сопровождалась более ранним купированием воспалительного процесса в молочной железе, выраженной активизацией гуморального и клеточного звена естественной резистентности, интенсивным снижением процессов пероксидации липидов и активизацией ферментативного и неферментативного звена антиоксидантной защиты. The article presents the results of studying the efficacy of the therapeutic regimen for bovine mastitis, including the use of the complex drug “Diomast-KRS” and Lipoton. For experimental studies, 49 cows with mastitis were selected, which were divided into 2 groups according to the principle of analogues. The animals of the first group were given “Diomast-KRS” according to the instructions, the second group was additionally administered Lipoton intramuscularly at a dose of 0.02 ml/kg twice with an interval of 48 hours. It had been found that the best therapeutic effect was obtained with the combined use of Lipoton and “Diomast-KRS”, which was 92.3 % for purulent-catarrhal mastitis, 91.7 % — for catarrhal mastitis, which was by 7.7—9.9 % higher than the baseline values, while 93.3 and 92.3 % of the udder lobes were cured, respectively. Milk contamination with microflora decreased by 4 times with the introduction of “Diomast-KRS”, and by 6 times with the additional use of Lipoton, while the bacterial carriage was by 1.5 times lower. Therapy of cows with mastitis using Lipoton was accompanied by earlier relief of the inflammatory process in the mammary gland, pronounced activation of the humoral and cellular links of natural resistance, an intensive decrease in lipid peroxidation processes and activation of the enzymatic and non-enzymatic links of antioxidant protection.
- Open Access
- 26 January 2024
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 4,p. 124-128
Study of acute toxity and wound healing effect of the complex ointment «Uberosept»
The design of drugs that allow the unlimited use of animal products is an important area of veterinary pharmacology. In this regard, in the production of a new complex ointment intended for treating the skin of the udder of cows, natural components were selected. The formula for “Uberosept” ointment includes ichthyol, pine resin and camphor. One of the important stages of preclinical study of new drugs is to identify their toxic properties and evaluate their efficacy. Therefore, the purpose of our work was to determine the toxicity class and study the wound-healing effect of “Uberosept”. The acute toxicity of “Uberosept” ointment was tested during intragastric administration using a fixed dose method (GOST 32296-2013) on female white mice. The wound healing effect was studied in a full-thickness skin wound model in female rats. It has been established that “Uberosept” ointment can be classified as hazard class 5. When administered intragastrically at a maximum dose of 5000 mg/kg during the first 30 minutes and the next 14 days, no signs of intoxication were detected in all experimental mice.
- 26 January 2024
- Published by Saint-Petersburg State University of Veterinary Medicine in Legal regulation in veterinary medicine
- No. 4,p. 124-128
Open AccessStudy of acute toxity and wound healing effect of the complex ointment «Uberosept»
The design of drugs that allow the unlimited use of animal products is an important area of veterinary pharmacology. In this regard, in the production of a new complex ointment intended for treating the skin of the udder of cows, natural components were selected. The formula for “Uberosept” ointment includes ichthyol, pine resin and camphor. One of the important stages of preclinical study of new drugs is to identify their toxic properties and evaluate their efficacy. Therefore, the purpose of our work was to determine the toxicity class and study the wound-healing effect of “Uberosept”. The acute toxicity of “Uberosept” ointment was tested during intragastric administration using a fixed dose method (GOST 32296-2013) on female white mice. The wound healing effect was studied in a full-thickness skin wound model in female rats. It has been established that “Uberosept” ointment can be classified as hazard class 5. When administered intragastrically at a maximum dose of 5000 mg/kg during the first 30 minutes and the next 14 days, no signs of intoxication were detected in all experimental mice.
- Open Access
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60 (4)
STUDY OF THE IRRITANT EFFECT AND ANTI-INFLAMMATORY ACTIVITY OF THE OINTMENT UBEROSEPT
The article presents the results of two series of experiments on studying the local irritant and anti-inflammatory action of a new complex ointment Uberosept. The studies of the anti-inflammatory activity of the drug were carried out on white rats using the zymosan-induced paw edema model. It has been found that the Uberosept ointment possesses pronounced anti-inflammatory properties, that are not inferior to the comparison drug (Hydrocortisone ointment). The experiments to assess the irritant effect of Uberosept were conducted on guinea pigs. The animals were applied the complex ointment at doses of 0.12 and 0.6 g to the skin used as a single dose, and at a dose of 0.12 g for 14 days. Based on the conducted studies, it can be concluded that the ointment Uberosept does not cause an irritant effect on the skin with a single or long-term use.
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60 (4)
Open AccessSTUDY OF THE IRRITANT EFFECT AND ANTI-INFLAMMATORY ACTIVITY OF THE OINTMENT UBEROSEPT
The article presents the results of two series of experiments on studying the local irritant and anti-inflammatory action of a new complex ointment Uberosept. The studies of the anti-inflammatory activity of the drug were carried out on white rats using the zymosan-induced paw edema model. It has been found that the Uberosept ointment possesses pronounced anti-inflammatory properties, that are not inferior to the comparison drug (Hydrocortisone ointment). The experiments to assess the irritant effect of Uberosept were conducted on guinea pigs. The animals were applied the complex ointment at doses of 0.12 and 0.6 g to the skin used as a single dose, and at a dose of 0.12 g for 14 days. Based on the conducted studies, it can be concluded that the ointment Uberosept does not cause an irritant effect on the skin with a single or long-term use.
- Open Access
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60 (4)
TOXICITY PARAMETERS OF A COMPLEX ANTIMICROBIAL DRUG BASED ON LEVOFLOXACIN USED ON WHITE MICE
The article presents the results of a study of the acute toxicity of a new antimicrobial drug based on levofloxacin. The trial was conducted on white laboratory mice, which were administered the drug under investigation once at different doses intragastrically and subcutaneously. As a result of the study, toxicity parameters were established, which made it possible to classify the new drug as Hazard class 4. The LD50 for subcutaneous administration for white mice was 13126.57±1537.49 mg/kg.
- 1 January 2024
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 60 (4)
Open AccessTOXICITY PARAMETERS OF A COMPLEX ANTIMICROBIAL DRUG BASED ON LEVOFLOXACIN USED ON WHITE MICE
The article presents the results of a study of the acute toxicity of a new antimicrobial drug based on levofloxacin. The trial was conducted on white laboratory mice, which were administered the drug under investigation once at different doses intragastrically and subcutaneously. As a result of the study, toxicity parameters were established, which made it possible to classify the new drug as Hazard class 4. The LD50 for subcutaneous administration for white mice was 13126.57±1537.49 mg/kg.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (4)
INDICATORS OF ANTIOXIDANT PROTECTION AND ENDOGENOUS INTOXICATION IN THE EARLY POSTPARTUM PERIOD WHEN USING THE DRUG PROAUTOVAK
The conducted studies found that the use of the drug Proautovak contributed to a more pronounced change in the indicators of the LPO-AOD system, so the concentration of MDA was by 28.8% lower, compared to the cows from the negative control group, IEI - by 18.7%, MWM - by 31.7%, NO - by 27.8%, with an increase in the content of vitamin A - by 50.0%, vitamin E - by 35.5% and vitamin C - by 32.8%, as well as catalase activity - by 27.5% and glutathione peroxidase - by 53.6% that indicated a decrease in the processes of lipid peroxidation and endogenous intoxication and activation of the enzymatic and non-enzymatic components of the antioxidant defense system.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (4)
INDICATORS OF ANTIOXIDANT PROTECTION AND ENDOGENOUS INTOXICATION IN THE EARLY POSTPARTUM PERIOD WHEN USING THE DRUG PROAUTOVAK
The conducted studies found that the use of the drug Proautovak contributed to a more pronounced change in the indicators of the LPO-AOD system, so the concentration of MDA was by 28.8% lower, compared to the cows from the negative control group, IEI - by 18.7%, MWM - by 31.7%, NO - by 27.8%, with an increase in the content of vitamin A - by 50.0%, vitamin E - by 35.5% and vitamin C - by 32.8%, as well as catalase activity - by 27.5% and glutathione peroxidase - by 53.6% that indicated a decrease in the processes of lipid peroxidation and endogenous intoxication and activation of the enzymatic and non-enzymatic components of the antioxidant defense system.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (4)
EFFECT OF THE DRUG PROSTIMUL ON THE INDICATORS OF ENDOGENOUS INTOXICATION AND ANTIOXIDANT PROTECTION IN SOWS
The article presents the results of studying the effect of the drug Prostimul on the indicators of endogenous intoxication and the antioxidant status of sows. It has been found that the use of Prostimul is accompanied by an increase in the indicators of enzymatic (catalase and glutathione peroxidase) and non-enzymatic (vitamins A, E and C) links of antioxidant protection, as well as a decrease in the content of transition products of free radical processes in the body of experimental animals. Since a decrease in the activity of the antioxidant system with an increase in the formation of free radicals and reactive metabolites is one of the basic mechanisms for the occurrence of various pathologies, it is possible to recommend the drug Prostimul as a means of prevention and pathogenetic therapy for the correction of free radical oxidation.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (4)
EFFECT OF THE DRUG PROSTIMUL ON THE INDICATORS OF ENDOGENOUS INTOXICATION AND ANTIOXIDANT PROTECTION IN SOWS
The article presents the results of studying the effect of the drug Prostimul on the indicators of endogenous intoxication and the antioxidant status of sows. It has been found that the use of Prostimul is accompanied by an increase in the indicators of enzymatic (catalase and glutathione peroxidase) and non-enzymatic (vitamins A, E and C) links of antioxidant protection, as well as a decrease in the content of transition products of free radical processes in the body of experimental animals. Since a decrease in the activity of the antioxidant system with an increase in the formation of free radicals and reactive metabolites is one of the basic mechanisms for the occurrence of various pathologies, it is possible to recommend the drug Prostimul as a means of prevention and pathogenetic therapy for the correction of free radical oxidation.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (3)
CLINICAL STATUS AND MORPHOBIOCHEMICAL BLOOD INDICATORS OF COWS IN THE STUDY OF SUBCHRONIC TOXICITY OF RECOMBINANT INTERFERON-λ
The article presents the results of studies on the subchronic toxicity of recombinant interferon-λ on Holstein cows. The animals of the first group served as the control, the cows of the second group were intramuscularly injected with the test drug at a therapeutic dose of 10.0 ml 1 time per day for 9 days. The potential toxic effect of recombinant interferon-λ was assessed by indicators of the physiological condition of animals (body temperature, pulse, number of respiratory movements and rumen contractions), as well as by morphological and biochemical blood indicators obtained before the experiment and a day after the last administration of the drug. It has been established that repeated administration of recombinant interferon-λ at a therapeutic dose does not have a negative effect on the clinical indicators of the cows' organism, morphological blood composition and basic metabolic indicators.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (3)
CLINICAL STATUS AND MORPHOBIOCHEMICAL BLOOD INDICATORS OF COWS IN THE STUDY OF SUBCHRONIC TOXICITY OF RECOMBINANT INTERFERON-λ
The article presents the results of studies on the subchronic toxicity of recombinant interferon-λ on Holstein cows. The animals of the first group served as the control, the cows of the second group were intramuscularly injected with the test drug at a therapeutic dose of 10.0 ml 1 time per day for 9 days. The potential toxic effect of recombinant interferon-λ was assessed by indicators of the physiological condition of animals (body temperature, pulse, number of respiratory movements and rumen contractions), as well as by morphological and biochemical blood indicators obtained before the experiment and a day after the last administration of the drug. It has been established that repeated administration of recombinant interferon-λ at a therapeutic dose does not have a negative effect on the clinical indicators of the cows' organism, morphological blood composition and basic metabolic indicators.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (1)
CHANGES IN THE BLOOD BIOCHEMICAL VALUES OF CALVES IN THE TREATMENT OF RESPIRATORY PATHOLOGY
Respiratory diseases of calves cause a great damage to cattle breeding. Various medications are used to cure animals. The objective of the work was to study the effect of the drugs sulfetrisan and gentaaminoseleferon on metabolic parameters in the treatment of calves. Upon the recovery of animals of the experimental group, normalization of blood biochemical values was registered in the animals of the experimental groups, that indicated a decrease in the inflammatory process in the respiratory organs. The use of gentaaminoseleferon provided a more intensive restoration of metabolism and, as a result, a high therapeutic efficacy.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (1)
CHANGES IN THE BLOOD BIOCHEMICAL VALUES OF CALVES IN THE TREATMENT OF RESPIRATORY PATHOLOGY
Respiratory diseases of calves cause a great damage to cattle breeding. Various medications are used to cure animals. The objective of the work was to study the effect of the drugs sulfetrisan and gentaaminoseleferon on metabolic parameters in the treatment of calves. Upon the recovery of animals of the experimental group, normalization of blood biochemical values was registered in the animals of the experimental groups, that indicated a decrease in the inflammatory process in the respiratory organs. The use of gentaaminoseleferon provided a more intensive restoration of metabolism and, as a result, a high therapeutic efficacy.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (1)
INDICATORS OF NATURAL RESISTANCE IN THE “AMSF” DRUG THERAPY OF CATARRHAL MASTITIS IN COWS
The article features changes in the indicators of cellular and humoral elements of natural resistance in the treatment of cows with catarrhal mastitis. It has been found that the additional inclusion of the immunomodulatory drug AMSF in the treatment regimen of animals is accompanied by a decrease in the inflammatory reaction in their mammary gland, as well as the activation of humoral and cellular elements of natural resistance.
- 1 January 2022
- Published by Vitebsk State Academy of Veterinary Medicine in Transactions of the educational establishment “Vitebsk the Order of “the Badge of Honor” State Academy of Veterinary Medicine
- Vol. 58 (1)
INDICATORS OF NATURAL RESISTANCE IN THE “AMSF” DRUG THERAPY OF CATARRHAL MASTITIS IN COWS
The article features changes in the indicators of cellular and humoral elements of natural resistance in the treatment of cows with catarrhal mastitis. It has been found that the additional inclusion of the immunomodulatory drug AMSF in the treatment regimen of animals is accompanied by a decrease in the inflammatory reaction in their mammary gland, as well as the activation of humoral and cellular elements of natural resistance.